期刊文献+

脑卒中患者早期康复的临床经济学评价 被引量:2

下载PDF
导出
摘要 目的:对脑卒中患者的早期康复进行临床经济学评价(clinical economic evaluation,CEA)。方法:采用前瞻性的随机对照试验(randomized controlled trial,RCT),用分层区组随机法将脑卒中患者分入综合康复组及一般康复组。通过观察早期康复对患者临床神经功能缺损程度(neurological deficits Scores,NDS)及日常生活活动能力(activities of daily living,ADL)的影响,采用成本-效果分析(cost-effectiveness analysis,CEA)对早期康复做相应的CEA。结果:综合康复组患者NDS每减少1分、ADL每提高1分需分别花费人民币1203.2元和402.6元;而一般康复组则分别需花费1715.9元和427.6元。CEA显示综合康复组较一般康复组NDS每减少1分、ADL每升高1分,分别需多花费170.9元和184.6元。结论:早期综合康复在降低患者NDS、提高ADL上较一般康复有更好疗效;综合康复在改善患者运动功能上更经济。
出处 《世界医学杂志》 2003年第15期63-65,共3页 International Journal of Medicine
  • 相关文献

参考文献14

  • 1张微微,张茁.什么是治疗缺血性卒中最理想的方法[J].世界医学杂志,2003,7(4):1-4. 被引量:9
  • 2陈清棠.脑血管疾病分类诊断要点,全国第四届脑血管病学术会议通过(1995)[J].中华神经科杂志,1996,29:379-383.
  • 3徐嘉玲,周东,文黎敏,王军,张捷,刘鸣,张勤.循证医学在神经内科的应用[J].中华医院管理杂志,2001,17(7):411-412. 被引量:16
  • 4肖卫忠,谢汝萍,王觉生,罗祖明.脑卒中患者早期强化康复治疗的卫生经济学评价[J].中国临床康复,2003,7(3):372-373. 被引量:29
  • 5苏莉娟 肖卫忠 隋伟.脑卒中患者早期康复的对照研究[J].中国综合临床,2003,19:43-43.
  • 6付桂敏,肖卫忠,李筱雯,姜军,段京平.早期强化康复治疗对脑卒中患者神经功能缺损及ADL的影响[J].中国康复医学杂志,2002,17(4):218-220. 被引量:9
  • 7Mayer SA, Copeland D, Bernardini GL. et al. Cost and outcome of mechanical ventilation for life-threatening stroke. Stroke 2000,31: 2346-2353.
  • 8Anderson C, Mhurchu CN, mbenach S, et al. Home or hospital for stroke rehabilitation results of a randomized controlled trial Ⅱ. Cost minimization analysisat 6 months. Stroke 2000,31: 1032-1037.
  • 9Porsdal V, Boysen G. Costs of health care and social services during the first year after ischemic stroke.Int J Technol Assess Health Care 1999.15: 573-574.
  • 10Smurawska LT, Alexandro AV. Cost of acute stroke care in Toronto, Canada.Stroke 1994, 25: 1628-1634.

二级参考文献24

  • 1脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15750
  • 2PhilipB. Gorelick, MD, MPH, FACE Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke pathogenesis and implications for therapy. Stroke, 2002,33: 862-875.
  • 3Relton JK, Rothwell N J, et al. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med, 1995,139: 4174-4177.
  • 4Olsson AG, Pears J, McKellar J, et al. Effect ofrosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia. Am J Cardiol,2001,88 (5): 504-508.
  • 5M Steiner, M Brainin. Helicopter-assisted stroke admissions increase the rate of systemic thrombolysis (Austrian stroke registry for acute stroke units). Cerebralvascular diseases abstracts-the 11^th European Stroke Conference, 2002, May 29-June 1: 53.
  • 6Wemer Hacke, Markku Kaste, Tom Skyhoj Olsen, Julien Bogousslavsky, Jean-MarcOrgogozo. Acute Treatment of Ischemic Stroke. Cerebral Vascular Disease,2000,10 (3): 22-33.
  • 7Paoletti R, Fahmy M, Mahla G, et al. Rosuvastatin demonstrates greater reduction of low-density lipoprotein cholesterol compared with pravastatin and simvastatin in hypercholesterolaemic patients: a randomized, double-blind study. J Cardiovasc Risk, 2001,8 (6): 383-390.
  • 8Chong PH, Yim BT. Rosuvastatin for the treatment of patients with hyperchol-esterolemia. Ann Pharmacother, 2002,36 (1): 93-101.
  • 9Adams HP, Bendixen BH, Kapple L J, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinnical trial. Stroke, 1993,24:35-41.
  • 10Evrard S & Bousser MG: Watershed cerebral infarcts. Sang Thrombose Vaisseau,1991, 3: 103-108.

共引文献57

同被引文献26

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部